Jan Nilsson
Director/Board Member at CanImGuide Therapeutics AB
Profile
Jan Nilsson is currently a Non-Executive Director at CanImGuide Therapeutics AB, a Director at Panion Animal Health AB, a Director at Urbicum Ledningskonsult AB, a Director at CarryGenes Therapeutics AB, and a Director at Immodulate Pharma AB.
His former positions include being the Chief Executive Officer & Director at Promore Pharma AB from 2011 to 2013, the Chief Executive Officer & Director at CombiGene AB from 2016 to 2023, the Chief Executive Officer at Neurovive Pharmaceutical AB from 2013 to 2016, the Chief Operating Officer at Abliva AB in 2016, and the Chief Commercial Officer at Pergamum AB.
Mr. Nilsson holds an MBA from the University of Uppsala and a graduate degree from the University of Gothenburg.
Jan Nilsson active positions
| Companies | Position | Start |
|---|---|---|
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Director/Board Member | - |
| Urbicum Ledningskonsult AB | Director/Board Member | - |
Panion Animal Health AB
 Panion Animal Health AB Agricultural Commodities/MillingProcess Industries Panion Animal Health AB engages in the development and commercialization of gene-therapeutic treatment of epileptic-type disorders in dogs and other animals. It specializes in combining modern neuroscience with recent advances in gene delivery. The company was founded in July 2015 and is headquartered in Hassleholm, Sweden. | Director/Board Member | 19/08/2019 |
CarryGenes Therapeutics AB
 CarryGenes Therapeutics AB Miscellaneous Commercial ServicesCommercial Services CarryGenes Therapeutics AB engages in the research and development of biotechnology. The private company is based in Stockholm, Sweden. | Director/Board Member | - |
| Immodulate Pharma AB | Director/Board Member | - |
Former positions of Jan Nilsson
| Companies | Position | End |
|---|---|---|
| COMBIGENE AB | Chief Executive Officer | 31/08/2023 |
| Neurovive Pharmaceutical AB | Chief Executive Officer | 31/08/2016 |
| ABLIVA AB | Chief Executive Officer | 13/03/2016 |
Promore Pharma AB
 Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Chief Executive Officer | 31/12/2012 |
| ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Jan Nilsson
| University of Gothenburg | Graduate Degree |
| University of Uppsala | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ABLIVA AB | Health Technology |
| COMBIGENE AB | Health Technology |
| Private companies | 8 |
|---|---|
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Health Technology |
Pergamum AB
 Pergamum AB Pharmaceuticals: MajorHealth Technology Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden. | Health Technology |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
| Urbicum Ledningskonsult AB | |
Panion Animal Health AB
Panion Animal Health AB Agricultural Commodities/MillingProcess Industries Panion Animal Health AB engages in the development and commercialization of gene-therapeutic treatment of epileptic-type disorders in dogs and other animals. It specializes in combining modern neuroscience with recent advances in gene delivery. The company was founded in July 2015 and is headquartered in Hassleholm, Sweden. | Process Industries |
CarryGenes Therapeutics AB
CarryGenes Therapeutics AB Miscellaneous Commercial ServicesCommercial Services CarryGenes Therapeutics AB engages in the research and development of biotechnology. The private company is based in Stockholm, Sweden. | Commercial Services |
| Immodulate Pharma AB | |
| Neurovive Pharmaceutical AB |
- Stock Market
- Insiders
- Jan Nilsson
